Translational Activities

Translational activities

Our goal is to provide a new class of antibiotics and innovative antimicrobial strategies by targeting in vivo pathogen behaviour, providing new hope in the fight against AMR.

To facilitate the development of novel anti-infective strategies, we have already initiated collaborations with several different industry partners aiming at compound screening and optimisation, evaluation of non-conventional antimicrobials, defining novel antibiotic targets, and predicting pharmacokinetic/pharmacodynamics (PK/PD) in humans. Through these collaborations, we ensure early knowledge and technology transfer and gain in-depth insights in industrial requirements and opportunities.

Our People           Our Mission